Le Lézard
Classified in: Health
Subject: PERSONNEL ANNOUNCEMENTS

Global Alzheimer's Platform Foundation Appoints Joni Henderson as Chief Partnerships Officer


WASHINGTON, DC--(Marketwired - February 13, 2017) - Global Alzheimer's Platform Foundation, a nonprofit dedicated to reducing the time, cost and risk of Alzheimer's clinical trials, today announced its appointment of Joni Henderson to Chief Partnerships Officer. In this role, Henderson will create strategic donor outreach programs and partnership opportunities involving corporations, foundations, community groups and individual donors.

"The Global Alzheimer's Platform Foundation is fundamentally changing the search for Alzheimer's treatment therapies. I am eager to join this team of leading experts and renowned doctors, researchers and clinicians dedicated to helping those who are at risk or suffering from Alzheimer's Disease," said Joni Henderson. "Together we will develop new approaches and expand our allies to fight this terrible disease."

Henderson most recently served as Vice President of Corporate Education Partnerships at Discovery Education, a division of Discovery Communications. In this role, she was responsible for developing K-12 education initiatives on topics such as STEM engagement, online safety, cancer awareness, and overall youth engagement in partnership with corporations, foundations, nonprofits and trade associations.

Henderson's previous roles include Vice President at the National Board for Professional Teaching Standards, Director of Capital Region Advancement and Corporate Relations at the Smithsonian, and a variety of positions at Meridian International Center and the Philadelphia Museum of Art. She currently serves as a member of the national board of the NEA Foundation and as a board member of Britepaths, a nonprofit serving the working poor in Northern Virginia. Henderson has a Master of Science degree in Arts Administration from Drexel University and a Bachelor of Science degree in Business Administration from University of Redlands. She currently resides in Fairfax, Virginia.

"The Global Alzheimer's Platform Foundation collaborates with local community leaders, foundations and corporate leaders to grow participation in Alzheimer's clinical research. Joni's expertise and wide range of innovative programming ideas will help us significantly towards reaching this goal," said John Dwyer, president of Global Alzheimer's Platform Foundation.

"Our foundation is committed to populating Alzheimer's clinical trials. Joni's experience in facilitating partnerships will help bring increased awareness to this disease and its horrifying effects on our economy and society at large," said George Vradenburg, chairman of Global Alzheimer's Platform Foundation and UsAgainstAlzheimer's.

For more information about GAP Foundation, visit www.globalalzplatform.org.

About Global Alzheimer's Platform Foundation
The Global Alzheimer's Platform Foundation was launched in 2015 by UsAgainstAlzheimer's and the Global CEO Initiative (CEOi) on Alzheimer's disease with the vision of creating an integrated global clinical trial network to reduce the time, cost and risk of Alzheimer's disease clinical trials, a critical factor in the pacing of efforts to speed an effective treatment of Alzheimer's disease to those with or at risk of the disease. Global Alzheimer's Platform Foundation, headquartered in Washington, D.C., aims to create a faster pathway to a treatment for Alzheimer's disease by 2025. It intends to do so by building a standing global clinical trial platform of willing individuals through novel web-based recruitment techniques coupled with a network of high performance clinical trial sites. Global Alzheimer's Platform Foundation also provides an organizational framework that links prominent research institutions, the private sector and government agencies in multiple countries to fight Alzheimer's disease.

For more information about GAP, please visit www.globalalzplatform.org.

Image Available: http://www.marketwire.com/library/MwGo/2017/2/10/11G129990/Images/Joni_Henderson-2115b50d0740aa0e9354a722f5ac9833.jpg


These press releases may also interest you

at 19:40
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

at 19:05
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

at 19:00
David J. Dykeman, co-chair of the Life Sciences & Medical...

at 18:30
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community.  Aspire Health experienced a data security incident that may have involved personal and...

at 17:21
Chemistree Technology Inc. (US OTC: CHMJF) (the "Company" or "Chemistree"), is pleased to announce that the adjourned extraordinary meeting of the holders of the 10% senior unsecured convertible debentures of the Company (the "Debentures") was...

at 17:15
Summary Product: Counterfeit Viagra, 100 mg sildenafil tabletsIssue: Health products - Product safety, Unauthorized productWhat to do: Immediately stop using and safely dispose of this product. Consult your health care provider if you have taken this...



News published on and distributed by: